ADPT
#1612
Adaptive Biotechnologies Corporation - Common Stock
21.4 3 USD
+0.02%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+1.95%
Variación mensual
+32.61%
Variación en los últimos 6 meses
+20.46%
Cambio anual
+24.16%
Cierres anteriores
21.0 2
Open
21.4 3
Mínimo
21.4 3
High
21.4 3
Volumen
195
Financials
- Market Capitalization 3.43 B
- Employee 624
- Founded 2009
- CEO Chad Robins
- Website www.adaptivebiotech.com
- Headquarter Washington, United States
- FIGI BBG001J2PFF5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-43.37
Relación precio/flujo de caja
7.34
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1577 |  DNLI Denali Therapeutics Inc. - Common Stock | 22.65 USD | -14.46% | -13.15% | +2.40% | +40.07% | 3.59 B USD | ||
| 1582 |  RCUS Arcus Biosciences, Inc. Common Stock | 28.34 USD | +0.93% | -5.03% | +16.00% | +208.04% | 3.56 B USD | ||
| 1616 |  DYN Dyne Therapeutics, Inc. - Common Stock | 23.78 USD | +0.59% | +1.62% | +26.96% | +1.58% | 3.40 B USD | ||
| 1627 |  ALMS Alumis Inc. - Common Stock | 27.28 USD | -2.92% | -6.16% | +18.20% | +504.88% | 3.37 B USD |